Yuankai Shi, M.D.
Cancer Hospital Chinese Academy of Medical Science
1
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Helena A Yu, MD
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Shared therapeutic areas:
James C Yang, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Arielle Elkrief, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Shared therapeutic areas:
Øystein Fløtten
Haukeland University Hospital, thoracic department
Shared therapeutic areas:
Cesare Gridelli, M.D.
S.G. Moscati Hopital, Avellino, Italy, Division of Medical Oncology
Shared therapeutic areas:
Joseph Aisner, MD
Rutgers Cancer Institute of New Jersey
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Cesare Gridelli, M.D.
San Giuseppe Moscati Hospital, Avellino, Italy
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D
National Cancer Institute, Naples Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Fu-Tsai Chung, M.D.
Chang Gung Memorial Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
All 1 trials loaded